Medicine and Dentistry
Association
100%
Bilirubin
22%
Blood Sampling
5%
Brain
5%
Brain Derived Neurotrophic Factor
100%
Cell Damage
5%
Clinical Decision Making
5%
Cross Sectional Study
5%
Evaluation Study
100%
Gestational Age
16%
Hospital
11%
Hyperbilirubinemia
100%
Laboratory
5%
Life
5%
Neonatal Hyperbilirubinemia
11%
Neurotropic Agent
5%
Prematurity
11%
Risk Assessment
11%
Serum
100%
INIS
bilirubin
36%
biochemistry
9%
blood
9%
brain
100%
colleges
9%
comparative evaluations
9%
control
9%
correlations
9%
damage
9%
decision making
9%
evaluation
100%
hospitals
18%
laboratories
9%
levels
100%
neonates
100%
risk assessment
9%
risks
9%
tools
9%
Nursing and Health Professions
Bilirubin
22%
Blood Level
5%
Brain Derived Neurotrophic Factor
100%
Clinical Decision Making
5%
Control
5%
Cross-Sectional Study
5%
Device Material
5%
Evaluation Study
100%
Gestational Age
16%
Hospital
5%
Hospital Admission
5%
Hyperbilirubinemia
100%
Laboratory
5%
Neonatal Hyperbilirubinemia
11%
Neonates
100%
Prematurity
11%
Sample
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bilirubin
22%
Brain Derived Neurotrophic Factor
100%
Cross-Sectional Study
5%
Hyperbilirubinemia
100%
Neonatal Hyperbilirubinemia
11%
Neurotropic Agent
5%
Prematurity
11%